Haemophilus species bacteremia in patients with cancer. A 13-year experience

Arch Intern Med. 1989 Jun;149(6):1341-5.

Abstract

We reviewed the clinical and laboratory presentation of Haemophilus species bacteremia at our institution, with special attention to predisposing and prognostic factors. Of 36 cases, 18 presented with pneumonia, 1 with cellulitis, and another with sinusitis. No cases of meningitis or endocarditis were detected. Most episodes were caused by Haemophilus influenzae, and the overall response rate to treatment was 72%. Factors including chronic obstructive pulmonary disease, alcoholism, prior splenectomy, and neutropenia did not play an important role in these patients' infections. Most of the isolates serotyped were found to be nontypable. The occurrence of ampicillin resistance was 6% throughout the study. Ampicillin, chloramphenicol, and second-generation cephalosporins were all effective therapeutic regimens. Bacteremia due to Haemophilus species remains an uncommon infection in patients with cancer, despite the predominance of traditional predisposing factors.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Drug Resistance, Microbial
  • Female
  • Haemophilus / drug effects
  • Haemophilus / isolation & purification
  • Haemophilus Infections / drug therapy
  • Haemophilus Infections / epidemiology*
  • Haemophilus Infections / microbiology
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Neoplasms / complications*
  • Pneumonia / epidemiology
  • Prognosis
  • Recurrence
  • Risk Factors
  • Sepsis / drug therapy
  • Sepsis / epidemiology*
  • Sepsis / microbiology

Substances

  • Anti-Bacterial Agents